VVOS

Vivos Therapeutics, Inc.

Healthcare · Medical Devices

$176.90 sample

+1.90 (+1.09%) 1D

Market cap

$564.2B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-23

Alerts

8

Price$176.90 +14.42% 3M daily closessample

176.90149.27

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider buy: Director
Oct 02INSInsider sell: 10% owner
Sep 23SECDEF 14A filed
Sep 16INSInsider sell: Chief Executive Officer
Sep 07INSInsider sell: EVP, Operations
Sep 01INSInsider buy: Director
Aug 26INSInsider sell: EVP, Operations
Aug 18INSInsider sell: Chief Financial Officer

Sign up to see the real VVOS record →

Company facts

SEC EDGAR registration

Name: Vivos Therapeutics, Inc.
Sector: Healthcare
Industry: Medical Devices
Smart-money score: -10sample, -100 to +100
Reporting currency: USD

Who is positioning in VVOS

sample

Insiders: 10 insider transactions over 90 days, net selling, $506.0M
Congress: 2 members traded over 90 days
Institutions · 13F: 11 funds hold $6.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$29.9B +22.1% y/y

Q4 2024Q3 2026

Inventory$16.6B +11.7% y/y

Q4 2024Q3 2026

Accounts receivable$13.3B +11.1% y/y

Q4 2024Q3 2026

Total debt$33.5B +6.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $226.4B +11.5% 3M
Sample peer B: $208.4B +10.5% 3M
Sample peer C: $473.5B +11.2% 3M
Sample peer D: $121.9B -11.0% 3M
Sample peer E: $412.3B -7.3% 3M